VISIPAQUE 270

iodixanol · GE Healthcare

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VISIPAQUE 270, covering 2011-04-18 to 2011-04-18. Get the full timeline:

Most recent: Clinical Trial Update: Pilot Study to Compare ISOVUE®-250 and VISIPAQUE™ 270 for Motion Artifact and Pain in Peripheral DSA [Phase 4]